Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kalos

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Cancer Biology & Therapy|February 13, 2010
HSP110 improves the anti-tumor effects of the cytotoxic T lymphocyte epitope E749-57 in mice: HSP110 as a peptide specific chaperone or adjuvant?Michael Kalos
Journal of Translational Medicine|March 18, 2010
An integrative paradigm to impart quality to correlative scienceMichael Kalos
Vaccine|January 18, 2003
Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospectsMichael Kalos
Cancer Immunology, Immunotherapy : CII|December 2, 2011
Muscle CARs and TcRs: turbo-charged technologies for the (T cell) massesMichael Kalos
Journal for Immunotherapy of Cancer|February 18, 2016
Chimeric antigen receptor-engineered T cells in CLL: the next chapter unfoldsMichael Kalos
Journal of Translational Medicine|August 20, 2011
Biomarkers in T cell therapy clinical trialsMichael Kalos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2018
CART Targeting of Solid Tumors: More Pieces to the PuzzleMichael Kalos
Translational Research : the Journal of Laboratory and Clinical Medicine|December 19, 2012
T cell-based gene therapy of cancerSaar Gill, Michael Kalos
Immunological Reviews|December 17, 2013
Adoptive immunotherapy for cancerMarco Ruella, Michael Kalos
Molecular Therapy Oncolytics|September 15, 2016
High-content molecular profiling of T-cell therapy in oncologyRuslan Novosiadly, Michael Kalos
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Cancer Biology & Therapy|February 13, 2010
HSP110 improves the anti-tumor effects of the cytotoxic T lymphocyte epitope E749-57 in mice: HSP110 as a peptide specific chaperone or adjuvant?Michael Kalos
Journal of Translational Medicine|March 18, 2010
An integrative paradigm to impart quality to correlative scienceMichael Kalos
Vaccine|January 18, 2003
Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospectsMichael Kalos
Cancer Immunology, Immunotherapy : CII|December 2, 2011
Muscle CARs and TcRs: turbo-charged technologies for the (T cell) massesMichael Kalos
Journal for Immunotherapy of Cancer|February 18, 2016
Chimeric antigen receptor-engineered T cells in CLL: the next chapter unfoldsMichael Kalos
Journal of Translational Medicine|August 20, 2011
Biomarkers in T cell therapy clinical trialsMichael Kalos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2018
CART Targeting of Solid Tumors: More Pieces to the PuzzleMichael Kalos
Translational Research : the Journal of Laboratory and Clinical Medicine|December 19, 2012
T cell-based gene therapy of cancerSaar Gill, Michael Kalos
Immunological Reviews|December 17, 2013
Adoptive immunotherapy for cancerMarco Ruella, Michael Kalos
Molecular Therapy Oncolytics|September 15, 2016
High-content molecular profiling of T-cell therapy in oncologyRuslan Novosiadly, Michael Kalos
Pageof 8